These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 38642558)
1. Generation of human alveolar epithelial type I cells from pluripotent stem cells. Burgess CL; Huang J; Bawa PS; Alysandratos KD; Minakin K; Ayers LJ; Morley MP; Babu A; Villacorta-Martin C; Yampolskaya M; Hinds A; Thapa BR; Wang F; Matschulat A; Mehta P; Morrisey EE; Varelas X; Kotton DN Cell Stem Cell; 2024 May; 31(5):657-675.e8. PubMed ID: 38642558 [TBL] [Abstract][Full Text] [Related]
2. Generation of human alveolar epithelial type I cells from pluripotent stem cells. Burgess CL; Huang J; Bawa P; Alysandratos KD; Minakin K; Morley MP; Babu A; Villacorta-Martin C; Hinds A; Thapa BR; Wang F; Matschulat AM; Morrisey EE; Varelas X; Kotton DN bioRxiv; 2023 Jan; ():. PubMed ID: 36711505 [TBL] [Abstract][Full Text] [Related]
3. Screening of factors inducing alveolar type 1 epithelial cells using human pluripotent stem cells. Ohnishi Y; Masui A; Suezawa T; Mikawa R; Hirai T; Hagiwara M; Gotoh S Stem Cell Reports; 2024 Apr; 19(4):529-544. PubMed ID: 38552636 [TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells. Schmeckebier S; Mauritz C; Katsirntaki K; Sgodda M; Puppe V; Duerr J; Schubert SC; Schmiedl A; Lin Q; Paleček J; Draeger G; Ochs M; Zenke M; Cantz T; Mall MA; Martin U Tissue Eng Part A; 2013 Apr; 19(7-8):938-51. PubMed ID: 23176317 [TBL] [Abstract][Full Text] [Related]
5. Directed induction of alveolar type I cells derived from pluripotent stem cells via Wnt signaling inhibition. Kanagaki S; Ikeo S; Suezawa T; Yamamoto Y; Seki M; Hirai T; Hagiwara M; Suzuki Y; Gotoh S Stem Cells; 2021 Feb; 39(2):156-169. PubMed ID: 33241896 [TBL] [Abstract][Full Text] [Related]
9. Generation of an alveolar epithelial type II cell line from induced pluripotent stem cells. Tamò L; Hibaoui Y; Kallol S; Alves MP; Albrecht C; Hostettler KE; Feki A; Rougier JS; Abriel H; Knudsen L; Gazdhar A; Geiser T Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L921-L932. PubMed ID: 30211653 [TBL] [Abstract][Full Text] [Related]
10. Wnt signaling regulates trans-differentiation of stem cell like type 2 alveolar epithelial cells to type 1 epithelial cells. Abdelwahab EMM; Rapp J; Feller D; Csongei V; Pal S; Bartis D; Thickett DR; Pongracz JE Respir Res; 2019 Sep; 20(1):204. PubMed ID: 31492143 [TBL] [Abstract][Full Text] [Related]
11. Generating 3D Spheres and 2D Air-Liquid Interface Cultures of Human Induced Pluripotent Stem Cell-Derived Type 2 Alveolar Epithelial Cells. Werder RB; Huang J; Abo KM; Hix OT; Minakin K; Alysandratos KD; Merritt C; Berthiaume K; Alber AB; Burgess CL; Kotton DN; Wilson AA J Vis Exp; 2022 Apr; (182):. PubMed ID: 35499347 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of Club Cells to Alveolar Epithelial Cells In Vitro. Zheng D; Soh BS; Yin L; Hu G; Chen Q; Choi H; Han J; Chow VT; Chen J Sci Rep; 2017 Jan; 7():41661. PubMed ID: 28128362 [TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells for treating cystic fibrosis: State of the science. Pollard BS; Pollard HB Pediatr Pulmonol; 2018 Nov; 53(S3):S12-S29. PubMed ID: 30062693 [TBL] [Abstract][Full Text] [Related]
14. High-Throughput Culture Method of Induced Pluripotent Stem Cell-Derived Alveolar Epithelial Cells. Becerra D; Wu T; Jeffs S; Ott HC Tissue Eng Part C Methods; 2021 Dec; 27(12):639-648. PubMed ID: 34751582 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of mouse induced pluripotent stem cells into alveolar epithelial cells in vitro for use in vivo. Zhou Q; Ye X; Sun R; Matsumoto Y; Moriyama M; Asano Y; Ajioka Y; Saijo Y Stem Cells Transl Med; 2014 Jun; 3(6):675-85. PubMed ID: 24763685 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in Human Induced Pluripotent Stem Cell-derived Alveolar Epithelial Type II Cells Revealed with ABCA3/SFTPC Reporters. Sun YL; Hurley K; Villacorta-Martin C; Huang J; Hinds A; Gopalan K; Caballero IS; Russo SJ; Kitzmiller JA; Whitsett JA; Beers MF; Kotton DN Am J Respir Cell Mol Biol; 2021 Oct; 65(4):442-460. PubMed ID: 34101541 [TBL] [Abstract][Full Text] [Related]
17. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Jacob A; Vedaie M; Roberts DA; Thomas DC; Villacorta-Martin C; Alysandratos KD; Hawkins F; Kotton DN Nat Protoc; 2019 Dec; 14(12):3303-3332. PubMed ID: 31732721 [TBL] [Abstract][Full Text] [Related]
18. Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease. Leibel SL; McVicar RN; Winquist AM; Snyder EY J Vis Exp; 2021 Apr; (170):. PubMed ID: 33900299 [TBL] [Abstract][Full Text] [Related]
19. Dlk1-Mediated Temporal Regulation of Notch Signaling Is Required for Differentiation of Alveolar Type II to Type I Cells during Repair. Finn J; Sottoriva K; Pajcini KV; Kitajewski JK; Chen C; Zhang W; Malik AB; Liu Y Cell Rep; 2019 Mar; 26(11):2942-2954.e5. PubMed ID: 30865885 [TBL] [Abstract][Full Text] [Related]
20. Wnt5a Promotes AT1 and Represses AT2 Lineage-Specific Gene Expression in a Cell-Context-Dependent Manner. Li C; Peinado N; Smith SM; Zhou J; Gao F; Kohbodi G; Zhou B; Thornton ME; Grubbs BH; Lee MK; Bellusci S; Borok Z; Chen YW; Minoo P Stem Cells; 2022 Jul; 40(7):691-703. PubMed ID: 35429397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]